Skip to contentBaker Biotech Capital III (GP), LLC — GENOMIC HEALTH INC insider: 300 transactions · InsiderLensBaker Biotech Capital III (GP), LLC
- 10% owner at IDERA PHARMACEUTICALS, INC. · on record since Mar 29, 2006
- 10% owner at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Feb 28, 2006
- 10% owner at TRANZYME INC · on record since Mar 14, 2012
- 10% owner at VIROPHARMA INC · on record since Mar 1, 2006
- Director at SEATTLE GENETICS INC /WA · on record since Jun 29, 2006
- 10% owner at SEATTLE GENETICS INC /WA · on record since Jun 29, 2006
- 10% owner at TAPESTRY PHARMACEUTICALS, INC · on record since Apr 28, 2006
- Director at TRIMERIS INC · on record since Apr 28, 2006
- 10% owner at TRIMERIS INC · on record since Apr 28, 2006
- Director at NEUROGEN CORP · on record since Apr 28, 2006
- 10% owner at NEUROGEN CORP · on record since Apr 28, 2006
- Director at GENOMIC HEALTH INC · on record since Sep 11, 2006
- 10% owner at ALLOS THERAPEUTICS INC · on record since Nov 30, 2006
- 10% owner at GENOMIC HEALTH INC · on record since Feb 21, 2007
- 10% owner at AUXILIUM PHARMACEUTICALS INC · on record since Mar 11, 2010
- 10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Aug 8, 2007
- 10% owner at ALTEON INC /DE · on record since Aug 3, 2007
- Director at INCYTE CORP · on record since Aug 3, 2007
- 10% owner at INCYTE CORP · on record since Dec 19, 2007
- 10% owner at AP PHARMA INC /DE/ · on record since Oct 28, 2009
- 10% owner at ADOLOR CORP · on record since Apr 28, 2010
- Director at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Apr 8, 2010
- 10% owner at VAXGEN INC · on record since Jul 29, 2010
- 10% owner at PHARMACYCLICS INC · on record since Aug 24, 2011
- 10% owner at XOMA LTD /DE/ · on record since Mar 8, 2012
Insider trading activity of Baker Biotech Capital III (GP), LLC
- Transactions on record
- 300
- since Feb 14, 2005
- Open-market buys
- 205
- $281.5M
- Open-market sells
- 39
- $26M
- Companies traded
- 13
- last filing Mar 5, 2012
Figures computed from official regulatory filings — methodology.
Companies where Baker Biotech Capital III (GP), LLC has traded
Track record of Baker Biotech Capital III (GP), LLC
Statistical track record
Free- Open-market buys
- 231
- Last buy
- Mar 5, 2012
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Baker Biotech Capital III (GP), LLC
Co-insiders of Baker Biotech Capital III (GP), LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $2.2M · Jun 1, 2009
Baker Biotech Capital II (Z) (GP), LLCGENOMIC HEALTH INC +7
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 5, 2012 | Buy | 69,783 | 30.07 USD | $2.1M | SEC |
| Mar 5, 2012 | Buy | 15,288 | 29.47 USD | $450.5K | SEC |
| Mar 5, 2012 | Buy | 91,459 | 29.52 USD | $2.7M | SEC |
| Mar 5, 2012 | Buy | 85,231 | 29.96 USD | $2.6M | SEC |
| Feb 16, 2012 | Buy | 349 | 28.96 USD | $10.1K | SEC |
| Feb 16, 2012 | Buy | 55,804 | 28.44 USD | $1.6M | SEC |
| Feb 16, 2012 | Buy | 32,125 | 28.88 USD | $927.8K | SEC |
| Feb 16, 2012 | Buy | 91,543 | 29.85 USD | $2.7M | SEC |
| Feb 16, 2012 | Buy | 93,088 | 29.61 USD | $2.8M | SEC |
| Jan 23, 2012 | Buy | 178,921 | 16.41 USD | $2.9M | SEC |
| Jan 23, 2012 | Buy | 45,574 | 16.84 USD | $767.5K | SEC |
| Jan 23, 2012 | Buy | 22,081 | 16.07 USD | $354.8K | SEC |
| Jan 23, 2012 | Other | 16,200 | 15.00 USD | $243K | SEC |
| Jan 23, 2012 | Buy | 43,644 | 16.90 USD | $737.6K | SEC |
| Jan 23, 2012 | BuyD | 162 | 1.25 USD | $202.5 | SEC |
| Jan 23, 2012 | Buy | 69,245 | 16.43 USD | $1.1M | SEC |
| Jan 23, 2012 | Buy | 10,327 | 16.07 USD | $166K | SEC |
| Jan 23, 2012 | OtherD | -162 | 1.25 USD | $202.5 | SEC |
| Jan 23, 2012 | BuyD | 87 | 1.50 USD | $130.5 | SEC |
| Jan 23, 2012 | Buy | 2,449 | 15.81 USD | $38.7K | SEC |
| Jan 23, 2012 | Buy | 72,997 | 16.88 USD | $1.2M | SEC |
| Jan 23, 2012 | Other | 8,700 | 15.00 USD | $130.5K | SEC |
| Jan 23, 2012 | OtherD | -87 | 1.50 USD | $130.5 | SEC |
| Dec 7, 2011 | Buy | 192,316 | 13.52 USD | $2.6M | SEC |
| Dec 7, 2011 | Buy | 1,023,128 | 13.89 USD | $14.2M | SEC |